Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Total 13F shares
-
23,992,773
-
Share change
-
-1,147,610
-
Total reported value
-
$73,177,085
-
Price per share
-
$3.05
-
Number of holders
-
64
-
Value change
-
-$3,517,981
-
Number of buys
-
19
-
Number of sells
-
28
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2019
As of 31 Dec 2019,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,992,773 shares.
The largest 10 holders included
Engine Capital Management, LP, DIMENSIONAL FUND ADVISORS LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, ROYCE & ASSOCIATES LP, DALTON GREINER HARTMAN MAHER & CO, KENNEDY CAPITAL MANAGEMENT, INC., VANGUARD GROUP INC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, and Harvey Partners, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.